OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q1 2018

Type / Class
Debt / NOTE 2.750%12/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2018 Q1 $0 $0 -$7,205,000 0
2017 Q4 $20,000,000 $7,205,000 -$2,722,000 35.5% 3
2017 Q3 $22,560,000 $10,147,000 -$209,000 47.0% 4
2017 Q2 $22,460,000 $10,505,000 +$250,000 50.0% 3
2017 Q1 $21,960,000 $10,928,000 -$15,795,000 54.75% 3
2016 Q4 $76,057,000 $20,441,000 -$8,617,191 27.5% 12
2016 Q3 $107,414,000 $29,131,000 -$905,195 27.5% 15
2016 Q2 $96,127,000 $33,466,000 -$4,702 33.94% 12
2016 Q1 $107,352,000 $44,016,000 -$323,066 39.84% 15
2015 Q4 $107,937,000 $64,286,000 -$531,052 59.31% 16
2015 Q3 $108,478,000 $75,368,000 +$179,448 69.4% 19
2015 Q2 $110,063,000 $102,179,000 +$1,888,302 93.5% 21
2015 Q1 $112,658,000 $129,991,000 +$3,014,003 115.19% 18
2014 Q4 $110,708,000 $111,201,000 +$95,283,000 100.44% 18